Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

被引：2
|
作者：
El Kinge, Abdul Rahman
Hatourn, Hassan A.
Mahfouz, Rami A. [2 ]
Otrock, Zaher K. [2 ]
Jabbour, Elias [3 ]
Kantarjian, Hagop [3 ]
Bazarbachi, Ali [1 ]
机构：
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷 / 04期
关键词：
ACUTE MYELOGENOUS LEUKEMIA; RELAPSE; CHEMOTHERAPY; PROPOSAL;
D O I：
10.1016/j.leukres.2008.05.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [31] Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin
    Gottardi, Michele
    Simonetti, Giorgia
    Sperotto, Alessandra
    Nappi, Davide
    di Rora, Andrea Ghelli Luserna
    Padella, Antonella
    Norata, Marianna
    Giannini, Maria Benedetta
    Musuraca, Gerardo
    Lanza, Francesco
    Cerchione, Claudio
    Martinelli, Giovanni
    CANCERS, 2021, 13 (18)
  • [32] The Evolving Use of Gemtuzumab Ozogamicin in Acute Myeloid Leukemia
    Walter, Roland B.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (03) : 152 - 154
  • [33] Post-remission therapy in acute myeloid leukemia: what should I do now?
    Blum, William
    HAEMATOLOGICA, 2008, 93 (06) : 801 - 805
  • [34] Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas
    Piccaluga, PP
    Martinelli, G
    Rondoni, M
    Malagola, M
    Gaitani, S
    Isidori, A
    Bonini, A
    Gugliotta, L
    Luppi, M
    Morselli, M
    Sparaventi, G
    Visani, G
    Baccarani, M
    LEUKEMIA & LYMPHOMA, 2004, 45 (09) : 1791 - 1795
  • [35] The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients
    L Pagano
    L Fianchi
    M Caira
    S Rutella
    G Leone
    Oncogene, 2007, 26 : 3679 - 3690
  • [36] Reprise: Gemtuzumab Ozogamicin for Older Patients With Acute Myeloid Leukemia
    Neuberg, Donna S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (32) : 3905 - 3906
  • [37] Approval summary: Gemtuzumab ozogamicin in relapsed acute myeloid leukemia
    Bross, PF
    Beitz, J
    Chen, G
    Chen, XH
    Duffy, E
    Kieffer, L
    Roy, S
    Sridhara, R
    Rahman, A
    Williams, G
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2001, 7 (06) : 1490 - 1496
  • [38] Gemtuzumab ozogamicin in non-acute promyelocytic acute myeloid leukemia
    Huetter, Marie-Luise
    Schlenk, Richard F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2011, 11 (10) : 1369 - 1380
  • [39] Efficacy and toxicity of gemtuzumab ozogamicin in patients with acute myeloid leukemia
    van der Heiden, PLJ
    Jedema, I
    Willemze, R
    Barge, RMY
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 76 (05) : 409 - 413
  • [40] Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future
    Gottardi, Michele
    Sperotto, Alessandra
    Di Rora, Andrea Ghelli Luserna
    Padella, Antonella
    Cangini, Delia
    Giannini, Maria B.
    Simonetti, Giorgia
    Martinelli, Giovanni
    Cerchione, Claudio
    MINERVA MEDICA, 2020, 111 (05) : 395 - 410
12345